英文名称 | 中文名称 | CAS | MF |
3H,6H-Oxazolo[3,4-c][1,2,3]triazole,3a,4-dihydro-6-(1-methylethyl)-,cis-(9CI)
|
|
111209-54-2
|
C7H13N3O
|
2H,6H-1,5-Oxathiocin
|
|
292-96-6
|
C6H8OS
|
2H,4H-1,4-Oxathiin
|
|
67239-54-7
|
|
2H,4H-1,2,3-Oxathiazine
|
|
27197-26-8
|
|
5H,7H-6-Oxa-2,3,4a,7a-tetraazacyclopent[cd]indene(9CI)
|
|
189131-28-0
|
C6H6N4O
|
1H,3H-[1,2,3]Oxadiazolo[4,3-c][1,4]thiazin-3-one,tetrahydro-,(3aR)-(9CI)
|
|
718621-54-6
|
C5H8N2O2S
|
1H,3H-[1,4]Oxazepino[4,3-a]benzimidazole(9CI)
|
|
69056-79-7
|
C11H10N2O
|
1H,3H-Oxazolo[3,4-a][1,4]diazepine(9CI)
|
|
394249-65-1
|
C7H8N2O
|
1H,3H-[1,3,5]Oxadiazepino[5,6-a]benzimidazole(9CI)
|
|
130935-44-3
|
C10H9N3O
|
3H,6H-Oxazolo[3,4-c][1,2,3]triazole,3a,4-dihydro-6-(1-methylethyl)-,trans-(9CI)
|
|
111209-55-3
|
C7H13N3O
|
1H,3H-Oxazolo[3,4-a]indol-1-one,3,3-dimethyl-(9CI)
|
|
820964-06-5
|
C12H11NO2
|
1H,3H-Oxazolo[3,4-d][1,4]diazepine(9CI)
|
|
264620-20-4
|
C7H8N2O
|
HIFLUORO(TM) PSEUDOMONAS AGAR BASE
|
|
|
|
1H,7H-Oxazolo[3,4-a][1,3]diazepine(9CI)
|
|
502494-13-5
|
C7H8N2O
|
4H,6H-Oxazolo[3,4:1,5]pyrrolo[3,4-d]isoxazole(9CI)
|
|
161382-80-5
|
C7H6N2O2
|
2H,6H-Oxazolo[3,4:1,2]pyrrolo[3,4-d]isoxazole(9CI)
|
|
163419-85-0
|
C7H6N2O2
|
1H,3H-Oxazolo[3,4-a]benzimidazole(9CI)
|
|
79569-32-7
|
C9H8N2O
|
1H,3H-[1,3,6]Oxadiazepino[3,4-a]benzimidazole(8CI,9CI)
|
|
28891-18-1
|
C10H9N3O
|
2H,7H-Oxazolo[3,4:1,2]pyrrolo[3,4-b]pyridine(9CI)
|
|
604788-19-4
|
C9H8N2O
|
2H,6H-Oxazolo[5,4,3-ij]quinolin-2-one, 6-[4-(2,5-dimethyl-1H-pyrrol-1-yl)phenyl]-7-hydroxy-8,9-bis(1-methylethoxy)- (9CI)
|
|
188825-09-4
|
C28H30N2O5
|
2H,6H-Oxazolo[5,4,3-ij]quinolin-2-one, 7-hydroxy-6-methyl-8,9-bis(1-methylethoxy)-
|
|
188824-76-2
|
C17H21NO5
|
2H,6H-Oxazolo[5,4,3-ij]quinolin-2-one, 6-(2-aminophenyl)-7-hydroxy-8,9-bis(1-methylethoxy)-
|
|
188825-10-7
|
C22H24N2O5
|
3H,6H-7-Oxa-2a,5-diazaacenaphthylene (9CI)
|
|
827040-93-7
|
C9H8N2O
|
2H,6H-Oxazolo[5,4,3-ij]quinolin-2-one, 6-(2-fluorophenyl)-7-hydroxy-8,9-bis(1-methylethoxy)-
|
|
188824-93-3
|
C22H22FNO5
|
1H,3H-2-Oxa-12a-azabenzo[k]cyclopent[cd]acephenanthrylene-1,5,10-trione, 2a,4,10b,11,12,12b-hexahydro-3,6-dihydroxy-4-methyl-, [2aS-(2a-alpha-,3-
|
|
108946-67-4
|
C21H17NO6
|
1H,3H-2-Oxa-12a-azabenzo[k]cyclopent[cd]acephenanthrylene-1,5,10-trione, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2a,4,10b,11,12,12b-hexahydro-4-
|
|
115215-82-2
|
C27H31NO5Si
|
2H,6H-Oxazolo[5,4,3-ij]quinolin-2-one, 7-hydroxy-8,9-bis(1-methylethoxy)-6-phenyl-
|
|
188824-86-4
|
C22H23NO5
|
2H,6H-Oxazolo[5,4,3-ij]quinoline-2,6-dione, 5-bromo-4,5-dihydro- (9CI)
|
|
75655-13-9
|
C10H6BrNO3
|
1H,3H-2-Oxa-12a-azabenzo[k]cyclopent[cd]acephenanthrylene-1,5,10-trione, 2a,4,10b,11,12,12b-hexahydro-3,6,9-trihydroxy-4-methyl- (9CI)
|
|
115267-96-4
|
C21H17NO7
|
5H,7H-Oxazolo[5,4,3-de]phenanthridine-5,7-dione
|
|
586979-30-8
|
C14H7NO3
|
2H,4H-[1,3]Oxazino[4,3-a]isoquinolin-4-one, 1,6,7,11b-tetrahydro-1-(hydroxymethyl)-9,10-dimethoxy-
|
|
100783-51-5
|
C15H19NO5
|
2H,6H-Oxazolo[5,4,3-ij]quinolin-2-one, 6-butyl-7-hydroxy-8,9-bis(1-methylethoxy)-
|
|
188824-80-8
|
C20H27NO5
|
1H,3H-Oxazolo[3,4:1,6]pyrido[3,4-b]indol-3-one, 5,6,11,11a-tetrahydro-1,1-dimethyl-
|
|
117643-92-2
|
C15H16N2O2
|
2H,6H-Oxazolo[5,4,3-ij]quinolin-2-one, 7-hydroxy-8,9-bis(1-methylethoxy)-
|
|
188824-74-0
|
C16H19NO5
|
2H,4H-[1,3]Oxazino[4,3-a]isoquinolin-4-one, 9,10-diethoxy-1,6,7,11b-tetrahydro-1-(hydroxymethyl)-
|
|
100783-52-6
|
C17H23NO5
|
2H,6H-Oxazolo[5,4,3-ij]quinoline-2,6-dione, 4,5-dihydro- (8CI,9CI)
|
|
28884-03-9
|
C10H7NO3
|
2H,4H-Oxazolo[5,4,3-ij]quinoline-4-thione, 6,7-dimethyl-
|
|
83367-37-7
|
C12H11NOS
|
2H,6H-Oxazolo[5,4,3-ij]quinolin-2-one, 7-hydroxy-6-(2-methoxyphenyl)-8,9-bis(1-methylethoxy)-
|
|
188824-92-2
|
C23H25NO6
|
2H,4H-Oxazolo[5,4,3-ij]quinoline-4-thione, 6-methyl-
|
|
83367-35-5
|
C11H9NOS
|
HIF-1α Monoclonal Antibody (Clone H1α67)
|
|
|
|
2H,3H-Oxeto[2,3-a]pyrrolizine(9CI)
|
|
115187-04-7
|
C8H7NO
|
2H,3H-Oxeto[3,2-d]pyrrolo[1,2-a]azepine(9CI)
|
|
700373-43-9
|
C10H9NO
|
5H,8H-Oxeto[3,2-d]-1,3-benzodioxole (9CI)
|
|
370884-25-6
|
C8H8O3
|
2H,4H-Oxireno[3,4]pyrrolo[1,2-c]oxazole(9CI)
|
|
155121-80-5
|
C6H5NO2
|
2H,4H-Oxireno[3,4]pyrrolo[1,2-c]oxazol-4-one,tetrahydro-,(1aS,6aR,6bR)-
|
|
765313-49-3
|
C6H7NO3
|
2H,4H-Oxireno[3,4]pyrrolo[1,2-c]oxazol-4-one,tetrahydro-,(1aR,6aR,6bS)-
|
|
765313-46-0
|
C6H7NO3
|
(+/-)-HIGENAMINE HCL
|
|
|
C16H18ClNO3
|
(+/-)-HIGENAMINE
|
DL-去甲基乌药碱
|
|
C16H17NO3
|
higenamine-1-carboxylic acid
|
HIGEN胺-1-甲酸
|
56632-94-1
|
C17H17NO5
|
4,4',4'',4'''-(21H,23H-Porphine-5,10,15,20-tetrayl)tetrakis(2-methoxyphenol)
|
5,10,15,20-四(4-羟基-3-甲氧基苯基)卟啉
|
22112-80-7
|
C48H38N4O8
|
21H,23H-Porphine, 2,3,5,7,8,10,12,13,15,17,18,20-dodecaphenylporphyrin
|
2,3,5,7,8,10,12,13,15,17,18,20-十二苯基卟啉
|
131507-72-7
|
C92H62N4
|
21H,23H-Porphine-7-propanoic acid, 3-carboxy-13-ethenyl-18-ethyl-7,8-dihydro-2,5,8,12,17-pentamethyl-, (7S,8S)-
|
二氢卟吩E4
|
550-52-7
|
C33H36N4O4
|
21H,23H-Porphine-2,18-dipropanoic acid, 7-ethenyl-12-(1-methoxyethyl)-3,8,13,17-tetramethyl-
|
|
327050-53-3
|
C35H38N4O5
|
21H,23H-Porphine-2,18-dipropanoic acid, 12-ethenyl-7-(1-methoxyethyl)-3,8,13,17-tetramethyl-
|
|
327050-60-2
|
C35H38N4O5
|
4,4',4'',4'''-(21H,23H-Porphyrin-5,10,15,20-tetrayl)tetrakis(benzoic acid methyl) ester
|
|
|
|
2,2',2'',2'''-(21H,23H-Porphyrin-5,10,15,20-tetryl)tetrakisphenol
|
|
|
|
4,4',4'',4'''-(2H,21H-Porphyrin-5,10,15,20-tetryl)tetrakisbenzenesulfonic acid
|
|
|
|
2,2',2'',2'''-(21H,23H-Porphyrin-5,10,15,20-tetryl)tetrabenzenamine
|
|
|
|
4,4',4'',4'''-(21H,23H-Porphyrin-5,10,15,20-tetryl)tetrakis(1-methylpyridinium)·4chloride
|
|
|
|
4,4',4'',4'''-(21H,23H-Porphyrin-5,10,15,20-tetryl)tetrakis[benzoic acid 4-[1'-(p-tolylmethyl)-4,4'-bipyridinium-1-ylmethyl]benzyl] ester
|
|
|
|
21H,23H-Porphyrazine
|
|
500-77-6
|
C16H10N8
|
4,4',4'',4'''-(21H,23H-Porphyrin-5,10,15,20-tetrayl)tetrakisbenzonitrile
|
|
|
|
3,3',3'',3'''-(21H,23H-Porphyrin-5,10,15,20-tetrayl)tetrakisaniline
|
|
|
|
(21H,23H-Porphyrin-5,10,15,20-tetrayl)tetrakis(1,4-phenylene)tetrakis(trimethylaminium)·4chloride
|
|
|
|
HIF-2α Polyclonal Antibody
|
|
|
|
HIF-3 protein
|
|
|
|
HIF-1 protein
|
|
|
|
HIGHAMYLOSECORNSTARCH
|
|
|
|
high-affinity glucose transporter
|
|
|
|
HIGH-ACTIVEGINKO
|
|
|
|
HIGHAMYLOPECTINPOTATO
|
|
|
|
HIGHAMYLOSESTARCH
|
|
|
|
HIGH-ALUMINALOW-SILICAWOOLS
|
|
|
|
HIGHAMYLOPECTINPOTATOCULTIVARS
|
|
|
|
HIGHAMYLOSEMAIZESTARCH
|
|
|
|
High alkali washing agent
|
高碱性清洗剂
|
|
|
high-aluminium molecular sieve catalytic cracking catalyst
|
高铝分子筛催化裂化催化剂
|
|
|
high absorbent resin acrylic acid-acrylamide copolymer (II)
|
丙烯酸-丙烯酰胺共聚物高吸水性树脂(II)
|
|
|
high absorbent resin from graft copolymer of acrylonitrile onto chitosan initiated by APS-STS
|
APS-STS壳聚糖-接枝丙烯腈高吸水性树脂
|
|
|
high auto-mobile coating
|
高级轿车涂料
|
|
|
high absorbent resin acrylic acrylamide copolymer (I)
|
丙烯酸-丙烯酰胺共聚物高吸水性树脂(I)
|
|
|
High-Binding 96-Well Strip Plate
|
|
|
|
High-Binding 96-Well Solid Plate
|
|
|
|
HIGHBLOODPRESSURE
|
|
|
|
HIGH-BEEFDIET
|
|
|
|
HIGHBETA-CAROTENEMAIZE
|
|
|
|
HIGH-BRANCEREAL
|
|
|
|
HIGHBOILINGPHOSPHONATES
|
|
|
|
HIGHBETA-CAROTENEORANGECARROTS
|
|
|
|
HIGH CONCENTRAION AICD SURROGATES FOR CLP 2/88 4-PACK
|
|
|
|
HIGH CONCENTRATION ACID EXTRACTABLE MATRIX SPIKES
|
|
|
|
High Concentration Acid Surrogates for CLP 2/88, 5.2 Ml @ 10,000 ug/Ml in Methanol
|
|
|
|
High Concentration GC/MS Kit
|
|
|
|
High carbon magnesia - powder
|
|
|
|
HIGH-CATALYTICCRACKEDDIESELFUEL
|
|
|
|
HIGHCALCIUMLOWPROTEINMILK
|
|
|
|
HIGHCOPPERSILVERAMALGAM
|
|
|
|
HIGH-CALCIUMSKIMMILK
|
|
|
|
High-capacity variable take-off splitter head
|
|
|
|
High concentration pigment
|
|
|
|